Insulin receptor substrate 2 (IRS-2) is a critical adaptor protein involved in signal transduction downstream of various receptor tyrosine kinases, particularly insulin and insulin-like growth factor 1 (IGF-1) receptors. Upon activation of these receptors by their respective ligands, IRS-2 becomes phosphorylated on multiple tyrosine residues, leading to the recruitment and activation of downstream signaling molecules. The primary function of IRS-2 is to relay extracellular signals to intracellular pathways involved in cell growth, survival, metabolism, and differentiation.
Activation of IRS-2 typically involves phosphorylation events initiated by ligand binding to receptor tyrosine kinases. Upon ligand binding, IRS-2 becomes phosphorylated at specific tyrosine residues, creating docking sites for proteins containing Src homology 2 (SH2) domains. These proteins, such as phosphatidylinositol 3-kinase (PI3K) and growth factor receptor-bound protein 2 (Grb2), bind to IRS-2 and propagate downstream signaling cascades. PI3K activation leads to the generation of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which in turn activates protein kinase B (Akt) and promotes cell survival and growth. Additionally, Grb2 binding to IRS-2 facilitates the activation of the Ras-Raf-MAP kinase pathway, which regulates cell proliferation and differentiation. Overall, activation of IRS-2 orchestrates a complex network of signaling events that regulate various cellular processes crucial for organismal homeostasis and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SC 26196 | 218136-59-5 | sc-361350 sc-361350A | 10 mg 50 mg | $158.00 $630.00 | 3 | |
PI3K inhibitor influencing the PI3K/Akt pathway. SC-26196 may indirectly modulate IRS-2 by suppressing the PI3K/Akt pathway, impacting IRS-2 activation and downstream signaling. | ||||||
BMS-536924 | 468740-43-4 | sc-507397 | 5 mg | $285.00 | ||
IGF-1R/IR inhibitor affecting IRS-2 phosphorylation. BMS-536924 may directly influence IRS-2 by inhibiting its phosphorylation through the IGF-1R/IR pathway, thereby modulating downstream effects. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor affecting PI3K/Akt signaling. Wortmannin may indirectly modulate IRS-2 by interfering with the PI3K/Akt pathway, impacting IRS-2 activation and downstream cellular responses. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multi-kinase inhibitor affecting MAPK/ERK and PI3K/Akt pathways. Sorafenib may potentially modulate IRS-2 by influencing both MAPK/ERK and PI3K/Akt pathways, impacting IRS-2 activation. | ||||||
BIX 02189 | 1094614-85-3 | sc-364436 sc-364436A | 5 mg 10 mg | $224.00 $386.00 | 5 | |
ERK inhibitor impacting the MAPK/ERK pathway. BIX02189 may potentially modulate IRS-2 by selectively inhibiting ERK signaling, influencing IRS-2 activation and downstream cellular responses. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor affecting inflammatory signaling. SB203580 can potentially impact IRS-2 by suppressing the p38 MAPK pathway, a regulator of IRS-2 activation and downstream signaling events. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor affecting the JNK pathway. SP600125 can potentially modulate IRS-2 by suppressing the JNK pathway, impacting IRS-2 activation and downstream cellular responses. | ||||||